The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996

Por Bulk, S, van Kemenade, F J, Rozendaal, L, Meijer, C J L M
Publicado em 2004

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases

Por Gök, M, Rozendaal, L, Berkhof, J, Visser, O, Meijer, C J L M, van Kemenade, F J
Publicado em 2011

Incidence and gender differences of slipped capital femoral epiphysis in the Netherlands from 1998–2010 combined with a review of the literature on the epidemiology of SCFE

Por Witbreuk, M. M., van Royen, B. J., Van Kemenade, F. J., Witte, B. I., van der Sluijs, J. A.
Publicado em 2013

Slipped capital femoral epiphysis and its association with endocrine, metabolic and chronic diseases: a systematic review of the literature

Por Witbreuk, M., van Kemenade, F. J., van der Sluijs, J. A., Jansma, E. P., Rotteveel, J., van Royen, B. J.
Publicado em 2013

TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial

Por van de Sande, A. J. M., Koeneman, M. M., Gerestein, C. G., Kruse, A. J., van Kemenade, F. J., van Beekhuizen, H. J.
Publicado no BMC Cancer (2018)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

Por Bulk, S, Berkhof, J, Bulkmans, N W J, Zielinski, G D, Rozendaal, L, van Kemenade, F J, Snijders, P J F, Meijer, C J L M
Publicado em 2006

High-risk HPV type-specific clearance rates in cervical screening

Por Bulkmans, N W J, Berkhof, J, Bulk, S, Bleeker, M C G, van Kemenade, F J, Rozendaal, L, Snijders, P J F, Meijer, C J L M
Publicado em 2007

The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screenin...

Por Heideman, D. A. M., Hesselink, A. T., van Kemenade, F. J., Iftner, T., Berkhof, J., Topal, F., Agard, D., Meijer, C. J. L. M., Snijders, P. J. F.
Publicado em 2013

Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region

Por Hesselink, A. T., Berkhof, J., van der Salm, M. L., van Splunter, A. P., Geelen, T. H., van Kemenade, F. J., Bleeker, M. G. B., Heideman, D. A. M.
Publicado em 2014

Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate

Por Bulkmans, N W J, Bulk, S, Ottevanger, M S, Rozendaal, L, Hellenberg, S M, van Kemenade, F J, Snijders, P J F, Boeke, A J P, Meijer, C J L M
Publicado em 2006

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency

Por Bulk, S, Berkhof, J, Rozendaal, L, Daalmeijer, N C Fransen, Gök, M, de Schipper, F A, van Kemenade, F J, Snijders, P J F, Meijer, C J L M
Publicado em 2007

HPV infection in women with and without cervical cancer in Conakry, Guinea

Por Keita, N, Clifford, G M, Koulibaly, M, Douno, K, Kabba, I, Haba, M, Sylla, B S, van Kemenade, F J, Snijders, P J F, Meijer, C J L M, Franceschi, S
Publicado em 2009

Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

Por Hesselink, A. T., Meijer, C. J. L. M., Poljak, M., Berkhof, J., van Kemenade, F. J., van der Salm, M. L., Bogaarts, M., Snijders, P. J. F., Heideman, D. A. M.
Publicado em 2013

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing

Por Kocken, M, Berkhof, J, van Kemenade, F J, Louwers, J A, Zaal, A, Nobbenhuis, M A E, Kenter, G, Snijders, P J F, Meijer, C J L M, Helmerhorst, T J M
Publicado em 2012

Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene

Por Creemers, S. G., van Koetsveld, P. M., van den Dungen, E. S. R., Korpershoek, E., van Kemenade, F. J., Franssen, G. J. H., de Herder, W. W., Feelders, R. A., Hofland, L. J.
Publicado no J Clin Endocrinol Metab (2016)

Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan

Por Raza, S A, Franceschi, S, Pallardy, S, Malik, F R, Avan, B I, Zafar, A, Ali, S H, Pervez, S, Serajuddaula, S, Snijders, P J F, van Kemenade, F J, Meijer, C J L M, Shershah, S, Clifford, G M
Publicado em 2010

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

Por Rijkaart, D C, Coupe, V M H, van Kemenade, F J, Heideman, D A M, Hesselink, A T, Verweij, W, Rozendaal, L, Verheijen, R H, Snijders, P J, Berkhof, J, Meijer, C J L M
Publicado em 2010

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

Por Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M
Publicado em 2012

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study

Por Uijterwaal, M H, Witte, B I, Van Kemenade, F J, Rijkaart, D, Ridder, R, Berkhof, J, Balfoort-van der Meij, G A M A, Bleeker, M C G, Snijders, P J F, Meijer, C J L M
Publicado em 2014

Comparison of GP5+/6+-PCR and SPF(10)-Line Blot Assays for Detection of High-Risk Human Papillomavirus in Samples from Women with Normal Cytology Results Who Develop Grade 3 Cervic...

Por Hesselink, A. T., van Ham, M. A. P. C., Heideman, D. A. M., Groothuismink, Z. M. A., Rozendaal, L., Berkhof, J., van Kemenade, F. J., Massuger, L. A. F. G., Melchers, W. J. G., Meijer, C. J. L. M., Snijders, P. J. F.
Publicado em 2008